1-800-710-4674

Blog Post

Return to News Blog

Feature Story

 

Blood & Marrow Transplant Program Earns Joint Commission Gold Seal of Approval

By OHC, All Posts, News, 0 comments
March 25, 2015

 
OHC The Joint Commission Gold Seal of Approval BMT Program

The Joint Commission’s Gold Seal of Approval for OHC’s Blood & Marrow Transplant program at Jewish Kenwood’s Blood Cancer Center.

Mercy Health’s Blood Cancer Center — whose Blood and Marrow Transplant team is powered by OHC physicians — has earned the Joint Commission’s Certification and Gold Seal of Approval®.

“The diagnosis of blood cancer is a terrible shock for too many,” says OHC President Randy Broun, MD. “But we continue to find hope and inspiration in the resolve of our patients and in the amazing results we see in them every day. We’re proud of our BMT team and our association with Mercy Health, a dedicated partner working tirelessly to put our patients first.”

“Our focus is on treating the patient, not solely the cancer,” adds OHC oncologist James H. Essell, MD, medical director of the Blood Cancer Center, located in the Jewish Hospital in Kenwood, Ohio.

The Gold Seal of Approval® is a certification award that recognizes dedication to continuous compliance with The Joint Commission’s state-of-the-art standards. The Jewish Hospital underwent a rigorous on-site review, during which a Joint Commission expert evaluated it for compliance with standards of care specific to the needs of blood and marrow transplant patients and families, including infection prevention and control, leadership and medication management, before earning the Gold Seal.

The Joint Commission’s Disease-Specific Care Certification Program is designed to evaluate clinical programs across the continuum of care. Certification requirements address three core areas:

  • compliance with consensus-based national standards
  • effective use of evidence-based clinical practice guidelines to manage and optimize care
  • an organized approach to performance measurement and improvement activities

In addition to this new certification, OHC’s Blood & Marrow Transplant program has earned FACT accreditation by the Foundation for Cellular Therapy. Only 194 centers in the world have achieved these rigorous quality standards, reflecting our commitment to providing quality patient care related to cellular therapy. The Blood Cancer Center is a collections and transplant center for the National Marrow Donor Program. It is a member of the Eastern Cooperative Oncology Group, the Blood and Marrow Transplant Clinical Trials Network and the Interlink Health Services Transplant Network and is a Blue Distinction Center for Transplants. In addition, through Mercy Health’s partnership with OHC, the Blood Cancer Center is able to connect patients with OHC’s strategic research partner, the Sarah Cannon Research Institute.

The Blood Cancer Center is the only center in Cincinnati that can provide the full range of care for adults with blood diseases, including blood and marrow transplants. In 2014, OHC’s BMT physicians at the Blood Cancer Center performed 110 transplants. The team at the Blood Cancer Center annually treats more than 120 new patients with acute leukemia and high grade lymphoma and participates in a wide range of research studies, including cord blood transplants. Last year, it enrolled more than 45 patients in clinical trials. Physicians in the Center will see any patient referred to them within three to five business days and will see patients with high-grade lymphoma or leukemia on the same day as referral. All OHC Blood Cancer Center physicians are board certified.

Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission evaluates and accredits more than 20,000 health care organizations and programs in the United States, including more than 10,600 hospitals and home care organizations, and more than 6,600 other health care organizations that provide long term care, behavioral health care, laboratory and ambulatory care services. The Joint Commission also certifies more than 2,400 disease-specific care programs such as stroke, heart failure, joint replacement and stroke rehabilitation, and 400 health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation’s oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission.

 
 

Leave a Reply

Your email address will not be published. Required fields are marked *